Costco Offers Discounted Weight Loss Drugs, But Affordability Remains a Concern
Table of Contents
A new partnership between Costco and Novo Nordisk is making popular weight loss medications more accessible, but experts caution the reduced price may still be out of reach for many. The deal provides Costco shoppers without insurance with a significant discount on GLP-1 medications like Wegovy and Ozempic.
Costco is offering a four-month supply of injectable pens for $499, roughly half the typical out-of-pocket cost. While a prescription from a doctor is still required, the discount addresses a major barrier to access, as many insurance plans do not cover these medications for weight management. Medicare and Medicaid generally only cover drugs like Ozempic when prescribed for conditions such as Type 2 diabetes. Without insurance, a month’s supply can easily exceed $1,000.
The Semaglutide Connection: Ozempic vs. Wegovy
Both Ozempic and Wegovy contain the same active ingredient, semaglutide, but are approved for different purposes and come in varying dosages, as previously explained by TODAY.com. Ozempic is primarily prescribed for managing Type 2 diabetes, while Wegovy is specifically approved for weight loss.
Is the Discount Enough?
Despite the price reduction, some healthcare professionals believe the Costco offer doesn’t go far enough. “This is definitely a step in the right direction, but it’s not necessarily getting the medicine to people who need it the most at a price that is affordable,” said Dr. Rekha Kumar, an endocrinologist and associate professor of clinical medicine at Weill Cornell, during an Oct. 3, 2025 segment on the TODAY show.
The Future of GLP-1 Medications
The landscape of GLP-1 medications is evolving. Both Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk have reported promising results in clinical trials for oral versions of their drugs. However, the potential cost savings of a pill form remain uncertain.
Risks of Unverified Alternatives
As demand for these medications surges, consumers are increasingly turning to unproven supplements and so-called “GLP-1 patches” marketed on social media. Previously, compound pharmacies offered cheaper alternatives, but the FDA has since increased restrictions due to concerns about safety and effectiveness. The FDA cautions that compounded drugs are not evaluated for safety or efficacy and may pose unknown risks to consumers.
Novo Nordisk President David Moore emphasized the importance of providing access to “real, authentic” medications through a trusted brand like Costco. “And we know that Costco is a trusted brand,” he added, highlighting the company’s commitment to patient safety and quality.
Related reading
